Colchicine treatment in community healthcare setting to prevent severe COVID-19
- PMID: 32855152
- DOI: 10.1136/annrheumdis-2020-218759
Colchicine treatment in community healthcare setting to prevent severe COVID-19
Keywords: anti-inflammatory agents; health care; inflammation; non-steroidal; outcome assessment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al.Ann Rheum Dis. 2022 Oct;81(10):e199. doi: 10.1136/annrheumdis-2020-218806. Epub 2020 Aug 27. Ann Rheum Dis. 2022. PMID: 32855151 No abstract available.
Comment on
-
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.Ann Rheum Dis. 2020 Oct;79(10):1286-1289. doi: 10.1136/annrheumdis-2020-217712. Epub 2020 Jul 30. Ann Rheum Dis. 2020. PMID: 32732245 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical